← All indications
Adrenal Insufficiency
Conditions in which the production of adrenal CORTICOSTEROIDS falls below the requirement of the body. Adrenal insufficiency can be caused by defects in the ADRENAL GLANDS, the PITUITARY GLAND, or the HYPOTHALAMUS.
Subtype terms (4)
More specific conditions that are subtypes of Adrenal Insufficiency in the MeSH hierarchy.
- Addison Disease
10 drugs (8 approved, 2 experimental)
- Adrenoleukodystrophy
41 drugs (25 approved, 16 experimental)
- Hypoaldosteronism
- Waterhouse-Friderichsen Syndrome
Drugs by status
Approved for this indication (3)
Phase 4 trials (8)
Phase 3 trials (2)
Phase 2 trials (2)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (20)
- Novo Nordisk
- University of Roma La Sapienza
- Azienda Ospedaliera San Giovanni Battista
- CAMC Health System
- Johns Hopkins University
- Nanjing Medical University
- Newcastle University
- University of Groningen
- University of Adelaide
- University of Bern
- University of Bologna
- West Virginia University
- Cardiff University
- University of British Columbia
- University of Copenhagen
- University of Basel
- Southeast University
- Max Planck Institute
- Methodist Cancer Center, Houston, Texas
- The University of Texas, Dallas
Organization Involved with Phase 3 Indications (17)
- DuoCort Pharma
- Shire
- Diurnal Limited
- National Center for Research Resources (NCRR)
- University of Virginia
- University of California, Los Angeles
- University of Montpellier
- University of Gothenburg
- University of Nantes
- University of Paris
- University of Tuebingen
- National Institute for Health Research, United Kingdom
- Aix-University of Marseille
- TAIN (Treatment of Adrenal Insufficiency in Neonates) consortium
- University of Grenoble
- Imperial College London
- Imperial Health Charity
Organization Involved with Phase 2 Indications (6)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (5)